A phase II trial of intraperitoneal cisplatin and etoposide as consolidation therapy in patients with Stage II-IV epithelial ovarian cancer following negative surgical assessment.

Source:http://linkedlifedata.com/resource/pubmed/id/9570993

Download in:

View as

General Info

PMID
9570993